BCSC Logo InvestRight
humburger icon
close icon
News & Insights

Investor Alert: BCSC issues warning about Pegasus Pharmaceuticals Group

The BC Securities Commission is warning the public about Pegasus Pharmaceuticals Group Inc. (Pegasus) and its associated companies:

• Careseng Cancer Institute Inc.
• Pegasus BioPark (Dalian) Co., Ltd.

Pegasus has been offering Pegasus bonds and debentures through its website (http://pegasusbonds.com) and sales agents. According to the company’s website, Pegasus is using the funds raised for cancer therapy clinics, new drug development and to upgrade manufacturing facilities.

The BCSC is concerned that Pegasus is offering these investments when it has not issued a prospectus or registered with the BCSC.  Furthermore, BCSC staff have concerns about the returns offered on the Pegasus investments, which are as high as 100% per annum.

The BCSC urges the public to be wary about investing in Pegasus or its associated companies.

The BCSC urges investors, agents, or members of the public who have been approached or have information about Pegasus Pharmaceuticals or any of its associated companies to contact the BCSC inquiries line at 604-899-6854 or 1-800-373-6393 (toll free).

Suggested Reading

More Resources

Crypto Quiz

Test Your Crypto Asset Knowledge.

i
This quiz is designed to introduce you to the basics of crypto assets. It is not intended to provide investment or financial advice, and should not be relied upon as a substitute for such advice.
1
QUESTION 1/10

Cryptocurrencies and blockchain are the same thing.